International Journal of Hyperthermia · 2015 · 23 citations · 26 references
MedicineAnesthesiologyPerioperative MedicineAnesthesiaChemotherapyHemostasisAnticoagulation TherapyThrombosisEpidural Catheter PlacementPerioperative CoagulopathyPeripheral Venous SamplingPlatelet Count MonitoringPlatelet Receptor BiologyUncontrolled Coagulopathy
PURPOSE: The purpose of this study is to evaluate the fluctuations of coagulation parameters during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) and confirm beyond doubt that epidural anaesthesia is safe with this type of operations. MATERIALS AND METHODS: This is a prospective clinical study of consecutive patients who had cytoreductive surgery and HIPEC. An epidural catheter was inserted into all patients. Peripheral venous blood samples in specific time points of the procedure were tested for complete blood count, prothrombin time (PT), activated partial thromboplastin time (aPTT), international normalised ratio (INR), fibrinogen, D-dimer, and expression of the GpIIb/IIIa platelet receptor. RESULTS: A total of 51 consecutive patients were included in this study. The initial mean (SD) platelet count decreased significantly to a mean of 250.6 (105.4) 10(9)/L (p < 0.001). Fibrinogen levels decreased to 295.9 (127.4) mg/dL (p = 0.009). D-dimer levels increased to 5.3 (3.1) mg/dL (p < 0.001). APTT increased from 30.8 (5.8) s to 35.1 (4.6). The mean INR increased significantly to 1.5 (0.5) (p < 0.001). The total number of GpIIb/IIIa platelet receptors showed no significant variation throughout the measurements and was 72603.2 before HIPEC, 80772.4 during, and 77432.1 after. All the parameters examined, despite significant fluctuations remained in levels that would permit perioperative epidural analgesia. No related complications were recorded. CONCLUSION: Our results support the belief that epidural analgesia is a safe option in cytoreductive surgery and HIPEC despite certain intraoperative fluctuations in coagulation parameters. It is of major importance to regulate any abnormalities observed during surgery. There are no available data regarding the occurrence of coagulopathy in the post-operative period.
26
Prevention of Venous Thromboembolism
William Geerts, John A. Heit, Charles Marc Samama · CHEST Journal · 2008 · 3.8K citations
Prevention of VTE in Nonorthopedic Surgical Patients
Michael K. Gould, David García, Sherry M. Wren et al. · CHEST Journal · 2012 · 2.1K citations · Full text
Paul H. Sugarbaker · Annals of Surgery · 1995 · 1.5K citations · Full text
Terence C. Chua, Brendan Moran, Paul H. Sugarbaker et al. · Journal of Clinical Oncology · 2012 · 1.1K citations · Full text